Description | TrkAisamemberoftheneurotrophictyrosinekinasereceptorfamily.Itisamembrane-boundreceptorthatuponneurotrophinbinding,phosphorylatesitselfandmembersoftheMAPKpathway.TrkAisrequiredforhigh-affinitybindingtonervegrowthfactor(NGF),neurotrophin-3andneurotrophin-4/5butnotbrain-derivedneurotrophicfactor(BDNF).TrkAleadstocelldifferentiationsandmayplayaroleinspecifyingsensoryneuronsubtypes.Ithasacrucialroleinthedevelopmentandfunctionofthenociceptivereceptionsystemaswellasestablishmentofthermalregulationviasweating.SUBUNIT:Existsinadynamicequilibriumbetweenmonomeric(lowaffinity)anddimeric(highaffinity)structures.SUBCELLULARLOCATION:Cellmembrane;single-passtypeImembraneprotein.EndocytosedtotheendosomesupontreatmentofcellswithNGF.ALTERNATIVEPRODUCTS:2namedisoformsproducedbyalternativesplicing.BothisoformshavesimilarBIOLOGicalproperties.TISSUESPECIFICITY:IsoformTrkA-IIisprimarilyexpressedinneuronalcells.IsoformTrkA-Iisfoundinnon-neuronaltissues.MutationsinTrkAhavebeenassociatedwithcongenitalinsensitivitytopain,anhidrosis,self-mutalatingbehaviour,mentalretardationandcancer. |
BatchNo. | Seeproductlabel |
Unitsize | 100µl |
Antigen | ExtracellulardomainofglycosylatedhumanTrkAproteinproducedinmammaliancellswasusedastheimmunogen. |
OtherNames | Tropomyosin-relatedkinasereceptor;Highaffinitynervegrowthfactorreceptor;Neurotrophictyrosinekinasereceptortype1;TRK1transformingtyrosinekinaseprotein;p140-TrkA;Trk-A;NTRK1;TRK; |
Accession | NTRK1_HUMAN |
Producedin | Rabbit |
Purity | Wholeserum |
Applications | IHC(1:1000dilution),WesternBlotting(denaturingandnon-reducingSDS-PAGE,1:1000-1:2500dilution),1-siteELISA(1:5000dilution).Biosensisrecommendsoptimaldilutions/concentrationsshouldbedeterminedbytheenduser. |
Specificity | Specificitywasdemonstratedbyimmunohistochemistry.Whenusedforimmunohistochemistryinratdorsalrootganglia,stainingisrestrictedtotheknowndistributionofTrkA,thatisinsmall,nociceptiveneurons. |
Cross-reactivity | Reactswithhuman,ratandmouseTrkA.Otherspeciesnotyettested. |
Form | Lyophilised |
Reconstitution | Reconstitutein100µlofsterilewater.Centrifugetoremoveanyinsolublematerial. |
Storage | Afterreconstitutionkeepaliquotsat-20ºCforahigherstABIlity,andat4ºCwithanappropriateantibacterialagent.Glycerol(1:1)maybeaddedforanadditionalstability.Avoidrepetitivefreeze/thawcycles. |
SpecificReferences | KobayashiKetal.(2015)NerveGrowthFactorSignalsasPossIBLePathogenicBioMarkersforPerineuralInvasioninAdenoidCysticCarcinom.OtolaryngolHeadNeckSurg.2015Aug;153(2):218-24.Species:Human.Application:IHC. UrenRTetal.(2014)Anovelroleofsuppressorofcytokinesignaling-2intheregulationofTrkAneurotrophinreceptorbiology.JNeuRochem.2014May;129(4):614-27.Species:Mouse.Application:IF. |
References | 1.ZhangFX,etal.(2005)BrainRes16;1062(1-2)pp.92-100. 2.GearhartDA,etal.(2006)JNeurosciMethods.150(2)pp.159-173. |
Biosensis专注于神经科学领域的抗体和试剂的开发,特别是神经营养因子和神经营养因子受体。 近30年来,Biosensis一直是该领域的全球领航者和OEM供应商。除神经营养因子,我们的神经科学产品组合还被广泛用于神经退行性疾病、神经发育和神经代谢的研究。重点研究领域包括阿尔茨海默氏症(AD)、帕金森氏症(PD)和肌萎缩侧索硬化(ALS)疾病,以及自噬和代谢应激障碍,包括肥胖、代谢综合征的研究、神经免疫学和炎症。